Genitourinary Cancer
News
FDA scrutinizes cancer therapies granted accelerated approval
News
Bladder cancer indication withdrawn for durvalumab
AstraZeneca has withdrawn durvalumab’s indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit...
Conference Coverage
Surveillance after testicular cancer: New approaches slash radiation exposure
Article
How has the pandemic affected rural and urban cancer patients?
Conference Coverage
CCR score can guide treatment decisions after radiation in prostate cancer
The score can identify patients with a low risk of metastasis who could potentially skip androgen deprivation therapy.
Conference Coverage
Liquid vs. tissue biopsy in advanced prostate cancer: Why not both?
Conference Coverage
Declines in PSA screening may account for rise in metastatic prostate cancers
Longitudinal reductions in PSA screening across U.S. states were associated with increased incidence of metastatic prostate cancer.
Conference Coverage
Managing cancer outpatients during the pandemic: Tips from MSKCC
MSKCC has established guiding principles on how to manage cancer patients during the pandemic.
News
Aspirin linked to reduced bladder, breast cancer mortality
“The results presented here add to the accumulating evidence that aspirin may improve survival for some cancers.”
Article
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.